Birth Control Practices in People of Childbearing Potential with Epilepsy

Overview

About this study

The pupose of this study is to characterize women's attitudes and perceptions about whether their contraception method affects their seizure frequency.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patient's sex assigned at birth is female
Patient is taking a daily anti-seizure medication to prevent seizures
Diagnosis of epilepsy/seizures for at least 1 year
Age 18-47 years old

Exclusion Criteria:

Unable to complete survey

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/24/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Kelsey Smith, M.D.	Open for enrollment	Contact information: Kelsey Smith M.D. Smith.Kelsey@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kelsey Smith, M.D.

Open for enrollment

Contact information:

Kelsey Smith M.D.

Smith.Kelsey@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials